← Brewed Up Insight No. 142

MedPlus's parent set the buyback limit, not the group

MedPlus's accounts at 31 March 2026, the parent company alone and the whole group, in ₹ crore. The lower, the parent's, caps a buyback the board can approve without a shareholder vote.

MedPlus's parent set the buyback limit, not the group

MedPlus's accounts at 31 March 2026, the parent company alone and the whole group, in ₹ crore. The lower, the parent's, caps a buyback the board can approve without a shareholder vote.

2 pairs of bars: retained profit of ₹1.5 crore for the parent against ₹651.6 crore for the group, and a buyback limit of ₹131.7 crore for the parent against ₹196.7 crore for the group.

₹ CRORE

Parent company aloneWhole group

The board approved ₹130 crore, 98.7% of this limit

The limit is 10% of paid-up capital and free reserves, on whichever accounts give the lower figure. Above it, shareholders must vote.

MedPlus Health Services, BSE filing of 10 November 2026: public announcement for the buyback, section 6 · 31 Mar 2026

Share it

The numbers

Embed it on your site

The code carries a credit line that links back to this page. Keep it with the chart.

Get in touch